文献速递创伤与烧伤心脑血管急症重症综合管理与镇静镇痛

青少年重型颅脑创伤静脉血栓栓塞预防的当前实践差异:创伤中心类型的影响

Current practice variations in venous thromboembolism prophylaxis for adolescents with severe traumatic brain injury: Trauma center type matters.
PubMed 文献 · J Trauma Acute Care Surg · 2025-03-10
一句话结论回顾性队列显示,青少年重型颅脑创伤的药物性静脉血栓栓塞预防在儿童创伤中心实施率仅28.5%,且血栓事件风险约为成人创伤中心的2.04倍。

该回顾性队列研究利用美国外科医师学会创伤质量改进项目数据库(2017—2021年),纳入14至18岁重型颅脑创伤患者7238例,比较成人创伤中心(ATC)、混合创伤中心(MTC)和儿童创伤中心(PTC)在药物性静脉血栓栓塞(VTE)预防的实施率和时机上的差异。结果显示,ATC、MTC、PTC的药物性VTE预防实施率分别为63.1%、59.0%、28.5%;首次预防的中位时间分别为4天、4天、6天(p<0.001)。与ATC相比,MTC和PTC的VTE预防实施可能性降低(aIRR分别为0.89和0.39)。PTC的VTE事件风险高于ATC(OR 2.04),而迟发性神经外科干预率无显著差异(OR 1.18)。作者认为需进一步研究这些差异的驱动因素并制定标准化方案。

要点

  • 在7238例14—18岁重型颅脑创伤患者中,药物性VTE预防实施率ATC为63.1%、MTC为59.0%、PTC为28.5%。
  • 首次药物性VTE预防的中位时间ATC为4天、MTC为4天、PTC为6天(p<0.001)。
  • 与ATC相比,MTC和PTC的VTE预防实施可能性降低:aIRR 0.89(95%CI 0.80-0.97)和aIRR 0.39(95%CI 0.32-0.47)。
  • PTC的VTE事件风险高于ATC(OR 2.04,95%CI 1.16-3.60),而迟发性神经外科干预率无显著差异(OR 1.18,95%CI 0.68-2.05)。
  • 作者认为需进一步研究这些实践差异的驱动因素并制定标准化方案。

适用人群与场景

  • 14至18岁重型颅脑创伤患者,数据来自美国外科医师学会创伤质量改进项目数据库(2017—2021年)。

研究设计与关键结果

  • 研究类型:回顾性队列研究,使用美国外科医师学会创伤质量改进项目数据库(2017—2021年),纳入14至18岁重型颅脑创伤患者7238例。
  • 药物性VTE预防实施率:ATC 63.1%、MTC 59.0%、PTC 28.5%。
  • 首次预防中位时间:ATC 4天、MTC 4天、PTC 6天(p<0.001)。
  • 与ATC相比,MTC的VTE预防实施aIRR 0.89(95%CI 0.80-0.97),PTC的aIRR 0.39(95%CI 0.32-0.47)。
  • PTC的VTE事件风险高于ATC(OR 2.04,95%CI 1.16-3.60)。
  • ATC与PTC的迟发性神经外科干预率无显著差异(OR 1.18,95%CI 0.68-2.05)。

证据类型、等级与局限

  • 证据类型:回顾性队列研究;证据等级:治疗/照护管理,Level III。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为需进一步研究这些实践差异的驱动因素并制定标准化方案。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: While severe traumatic brain injury (TBI) faces an increased risk of venous thromboembolism (VTE), pharmacological VTE prophylaxis might be significantly delayed because of concerns for TBI progression. We aimed to assess practice variations in the rate and timing of VTE prophylaxis for adolescent patients with severe TBI between different trauma center types.

METHODS: This retrospective cohort study using the American College of Surgeon Trauma Quality Improvement Program database (2017-2021) included patients aged 14 to 18 years with severe TBI. Trauma centers were classified as follows: adult trauma center (ATC), mixed trauma center (MTC), and pediatric trauma center (PTC). We developed a multilevel mixed-effect Poisson regression model to assess the association between trauma center type and the rate and timing of VTE prophylaxis. Effect sizes for fixed effects were reported as adjusted incidence rate ratio (aIRR) with 95% confidence interval (CI). Secondary outcomes included the incidence of VTE and late neurosurgical interventions (>72 hours).

RESULTS: Of 7,238 eligible patients, pharmacological VTE prophylaxis was performed in 63.1% at ATC, 59.0% at MTC, and 28.5% at PTC. The median time to the initial prophylaxis was 4 days at ATC, 4 days at MTC, and 6 days at PTC ( p < 0.001). In the regression model, treatment at MTC and PTC was associated with decreased likelihood of VTE prophylaxis (aIRR, 0.89 [95% CI, 0.80-0.97] and aIRR, 0.39 [95% CI, 0.32-0.47]) compared with ATC. Treatment at PTC was associated with higher odds of VTE events (odds ratio, 2.04; 95% CI, 1.16-3.60), while there was no significant difference in the rate of late neurosurgical interventions between ATC and PTC (odds ratio, 1.18; 95% CI, 0.68-2.05).

CONCLUSION: We observed significant practice variations in the use of pharmacological VTE prophylaxis for adolescent patients with severe TBI between ATC, MTC, and PTC. Further research is warranted to investigate potential drivers of these variations and develop standardized protocols.

LEVEL OF EVIDENCE: Therapeutic/Care management; Level III.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Katsura M, Fukuma S, Miyata S, et al. Current practice variations in venous thromboembolism prophylaxis for adolescents with severe traumatic brain injury: Trauma center type matters. J Trauma Acute Care Surg. 2025. PMID: 40059104. doi:10.1097/TA.0000000000004586

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。